{"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}],"groups":[{"description":"Participants orally received BBI608 (480 mg) twice daily plus intravenously received Pem (500 mg/m2) and CDDP (75 mg/m2) on Day 3 in only Cycles 1 and on Days 1 in Cycles 2 and subsequent cycles.\n\nPremeditation with folic acid and vitamin B12 was given to reduce occurrence of serious adverse drug reactions, with reference to the package insert for Pem. Each cycle was defined as 21 days.","id":"BG000","title":"MPM or NSCLC: BBI608 + Pem + CDDP (Phase 1 Part)"},{"description":"Participants orally received BBI608 (480 mg) twice daily plus intravenously received Pem (500 mg/m2) and CDDP (75 mg/m2) on Day 3 in only Cycles 1 and on Days 1 in Cycles 2 and subsequent cycles.\n\nPremeditation with folic acid and vitamin B12 was given to reduce occurrence of serious adverse drug reactions, with reference to the package insert for Pem. Each cycle was defined as 21 days.","id":"BG001","title":"MPM: BBI608 + Pem + CDDP (Phase 2 Part)"},{"description":"Total of all reporting groups","id":"BG002","title":"Total"}],"measures":[{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"5.00","value":"64.5"},{"groupId":"BG001","spread":"10.71","value":"65.6"},{"groupId":"BG002","spread":"9.854","value":"65.5"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Age, Continuous","unitOfMeasure":"years"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"22"},{"groupId":"BG002","value":"25"}],"title":"Male"}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"Unknown or Not Reported"}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"25"}],"title":"MPM"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"NSCLC"}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Primary cancer","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"10.278","value":"58.53"},{"groupId":"BG001","spread":"7.661","value":"63.11"},{"groupId":"BG002","spread":"8.025","value":"62.45"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Weight","unitOfMeasure":"kg"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"14"}],"title":"0"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"14"}],"title":"1"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"2<="}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"description":"The Eastern Cooperative Oncology Group (ECOG) performance status measures patients' disease status on the following scale: 0=Fully active, able to carry on all pre-disease performance without restriction; 1=Restricted in physically strenuous activity, ambulatory and able to carry out work of a light nature; 2=Ambulatory and capable of all selfcare, unable to carry out any work activities. Up and about \\>50% of waking hours; 3=Capable of only limited selfcare, confined to bed or chair \\>50% of waking hours; 4=Completely disabled. Totally confined to bed or chair; 5=Dead","paramType":"COUNT_OF_PARTICIPANTS","title":"ECOG PS","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"STAGE I"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"2"}],"title":"STAGE II"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"5"}],"title":"STAGE III"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"17"},{"groupId":"BG002","value":"18"}],"title":"STAGE IV"}],"denoms":[{"counts":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"25"}],"units":"Participants"}],"title":"MPM"},{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"STAGE I"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"STAGE II"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"STAGE III"},{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"STAGE IV"}],"denoms":[{"counts":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"units":"Participants"}],"title":"NSCLC"}],"description":"Most types of cancer have four stages: stages I (1) to IV (4). Some cancers also have a stage 0 (zero). Lower stages indicate that the disease is more localized, or contained, whereas higher stages refer to cancers that have spread into other areas of the body: Stage 0 = cancer in situ, which means \"in place\"; Stage I = a small cancer or tumor that has not grown deeply into nearby tissues; Stage II and III = larger cancers or tumors that have grown more deeply into nearby tissue; Stage IV = the cancer has spread to other organs or parts of the body.","paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Of 4 participants in Phase 1 part, 3 participants with NSCLC and 1 participant with MPM enrolled.","title":"Disease classification","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"17"}],"title":"EPITHELIOID"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"3"},{"groupId":"BG002","value":"3"}],"title":"SARCOMATOID"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"5"}],"title":"BIPHASIC"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"OTHER"}],"denoms":[{"counts":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"25"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Of 4 participants in Phase 1 part, 3 participants with NSCLC and 1 participant with MPM enrolled.","title":"Tissue classification (MPM)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"title":"ADENOCARCINOMA"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"SQUAMOUS CELL CARCINOMA"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"LARGE CELL CARCINOMA"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"}],"title":"OTHER"}],"denoms":[{"counts":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"3"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Of 4 participants in Phase 1 part, 3 participants with NSCLC and 1 participant with MPM enrolled.","title":"Tissue classification (NSCLC)","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"14"}],"title":"Yes"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"13"},{"groupId":"BG002","value":"14"}],"title":"No"}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Metastases","unitOfMeasure":"Participants"},{"classes":[{"categories":[{"measurements":[{"groupId":"BG000","spread":"2.866","value":"3.91"},{"groupId":"BG001","spread":"0.726","value":"0.91"},{"groupId":"BG002","spread":"1.562","value":"1.34"}]}],"denoms":[{"counts":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"24"},{"groupId":"BG002","value":"28"}],"units":"Participants"}]}],"dispersionType":"STANDARD_DEVIATION","paramType":"MEAN","title":"Disease duration","unitOfMeasure":"month"}],"populationDescription":"Participants were NOT enrolled in Phase 1 and Phase 2 in duplicate."}